300 related articles for article (PubMed ID: 32708036)
1. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD).
Savic D; Hodson L; Neubauer S; Pavlides M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32708036
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
3. L-Carnitine Improves Skeletal Muscle Fat Oxidation in Primary Carnitine Deficiency.
Madsen KL; Preisler N; Rasmussen J; Hedermann G; Olesen JH; Lund AM; Vissing J
J Clin Endocrinol Metab; 2018 Dec; 103(12):4580-4588. PubMed ID: 30219858
[TBL] [Abstract][Full Text] [Related]
4. Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice.
Quesada-Vázquez S; Colom-Pellicer M; Navarro-Masip È; Aragonès G; Del Bas JM; Caimari A; Escoté X
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684533
[TBL] [Abstract][Full Text] [Related]
5. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial.
Saneian H; Khalilian L; Heidari-Beni M; Khademian M; Famouri F; Nasri P; Hassanzadeh A; Kelishadi R
J Pediatr Endocrinol Metab; 2021 Jul; 34(7):897-904. PubMed ID: 33939897
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study.
Hazzan R; Abu Ahmad N; Slim W; Mazen E; Neeman Z
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7522-7532. PubMed ID: 36314323
[TBL] [Abstract][Full Text] [Related]
7. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
8. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
9. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long-chain acyl-CoA dehydrogenase KO mouse.
Ranea-Robles P; Yu C; van Vlies N; Vaz FM; Houten SM
J Inherit Metab Dis; 2020 May; 43(3):486-495. PubMed ID: 31845336
[TBL] [Abstract][Full Text] [Related]
10. Significance of l-carnitine for human health.
Adeva-Andany MM; Calvo-Castro I; Fernández-Fernández C; Donapetry-García C; Pedre-Piñeiro AM
IUBMB Life; 2017 Aug; 69(8):578-594. PubMed ID: 28653367
[TBL] [Abstract][Full Text] [Related]
11. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver.
Fujisawa K; Takami T; Matsuzaki A; Matsumoto T; Yamamoto N; Terai S; Sakaida I
Sci Rep; 2017 Jun; 7(1):2749. PubMed ID: 28584294
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis.
Vogli S; Naska A; Marinos G; Kasdagli MI; Orfanos P
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686767
[TBL] [Abstract][Full Text] [Related]
15. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
[TBL] [Abstract][Full Text] [Related]
16. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
Jegatheesan P; Beutheu S; Ventura G; Sarfati G; Nubret E; Kapel N; Waligora-Dupriet AJ; Bergheim I; Cynober L; De-Bandt JP
Clin Nutr; 2016 Feb; 35(1):175-182. PubMed ID: 25736031
[TBL] [Abstract][Full Text] [Related]
17. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
18. (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice.
Dong Y; Lu H; Li Q; Qi X; Li Y; Zhang Z; Chen J; Ren J
Life Sci; 2019 Sep; 232():116644. PubMed ID: 31301418
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
[TBL] [Abstract][Full Text] [Related]
20. Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice.
Sun C; Guo Y; Cong P; Tian Y; Gao X
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
